Vanhanen I - Search Results

1

Glutamate and high-dose glucose-insulin-potassium (GIK) in the treatment of severe cardiac failure after cardiac operations.

Svedjeholm R, Huljebrant I, Håkanson E, Vanhanen I. Svedjeholm R, et al. Among authors: vanhanen i. Ann Thorac Surg. 1995 Feb;59(2 Suppl):S23-30. doi: 10.1016/0003-4975(94)00918-w. Ann Thorac Surg. 1995. PMID: 7840695 Clinical Trial.

2

Physiologic aspects in postoperative cardiac patients.

Håkanson E, Svedjeholm R, Vanhanen I. Håkanson E, et al. Among authors: vanhanen i. Ann Thorac Surg. 1995 Feb;59(2 Suppl):S12-4. doi: 10.1016/0003-4975(94)00902-j. Ann Thorac Surg. 1995. PMID: 7840693 Review.

3

Rationale for metabolic support with amino acids and glucose-insulin-potassium (GIK) in cardiac surgery.

Svedjeholm R, Håkanson E, Vanhanen I. Svedjeholm R, et al. Among authors: vanhanen i. Ann Thorac Surg. 1995 Feb;59(2 Suppl):S15-22. doi: 10.1016/0003-4975(94)00917-v. Ann Thorac Surg. 1995. PMID: 7840694 Review.

4

Metabolic and hemodynamic effects of intravenous glutamate infusion early after coronary operations.

Svedjeholm R, Vanhanen I, Håkanson E, Joachimsson PO, Jorfeldt L, Nilsson L. Svedjeholm R, et al. Among authors: vanhanen i. J Thorac Cardiovasc Surg. 1996 Dec;112(6):1468-77. doi: 10.1016/S0022-5223(96)70005-3. J Thorac Cardiovasc Surg. 1996. PMID: 8975838

5

Intravenous aspartate infusion after a coronary operation: effects on myocardial metabolism and hemodynamic state.

Vanhanen I, Håkanson E, Jorfeldt L, Svedjeholm R. Vanhanen I, et al. Ann Thorac Surg. 1998 May;65(5):1296-302. doi: 10.1016/s0003-4975(98)00155-6. Ann Thorac Surg. 1998. PMID: 9594855

6

Assessment of myocardial glutamate requirements early after coronary artery bypass surgery.

Vanhanen I, Svedjeholm R, Håkanson E, Joachimsson PO, Jorfeldt L, Nilsson L, Vanky F. Vanhanen I, et al. Scand Cardiovasc J. 1998;32(3):145-52. doi: 10.1080/14017439850140102. Scand Cardiovasc J. 1998. PMID: 9764429

7

Myocardial uptake and release of substrates in patients operated for unstable angina: impact of glutamate infusion.

Vanhanen I, Håkanson E, Jorfeldt L, Svedjeholm R. Vanhanen I, et al. Scand Cardiovasc J. 2003 May;37(2):113-20. doi: 10.1080/14017430310001230. Scand Cardiovasc J. 2003. PMID: 12775312 Clinical Trial.

8

A metabolic protective strategy could improve long-term survival in patients with LV-dysfunction undergoing CABG.

Svedjeholm R, Vidlund M, Vanhanen I, Håkanson E. Svedjeholm R, et al. Among authors: vanhanen i. Scand Cardiovasc J. 2010 Feb;44(1):45-58. doi: 10.3109/14017430903531008. Scand Cardiovasc J. 2010. PMID: 20141344 Free article.

9

Resection of a plasma cell granuloma combining a conventional posterolateral left-sided thoracotomy with a minimally invasive valve approach.

Kvitting JPE, Hermansson U, Vanhanen I. Kvitting JPE, et al. Among authors: vanhanen i. Gen Thorac Cardiovasc Surg. 2019 Oct;67(10):894-896. doi: 10.1007/s11748-018-0986-y. Epub 2018 Aug 11. Gen Thorac Cardiovasc Surg. 2019. PMID: 30099709

10

Correction to: Resection of a plasma cell granuloma combining a conventional posterolateral left-sided thoracotomy with a minimally invasive valve approach.

Kvitting JPE, Hermansson U, Vanhanen I. Kvitting JPE, et al. Among authors: vanhanen i. Gen Thorac Cardiovasc Surg. 2020 Jan;68(1):91. doi: 10.1007/s11748-019-01242-z. Gen Thorac Cardiovasc Surg. 2020. PMID: 31721095

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results